Sudarshan Pharma Industries Limited (BOM:543828)
India
· Delayed Price · Currency is INR 24.91
-0.38 (-1.50%)
At close: Mar 9, 2026
BOM:543828 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Operating Revenue | 6,437 | 5,050 | 4,635 | 4,613 | 3,571 | 1,934 | Upgrade
|
| Other Revenue | - | - | - | - | - | 1.74 | Upgrade
|
| Revenue | 6,437 | 5,050 | 4,635 | 4,613 | 3,571 | 1,935 | Upgrade
|
| Revenue Growth (YoY) | 40.15% | 8.95% | 0.48% | 29.19% | 84.52% | 30.77% | Upgrade
|
| Cost of Revenue | 5,681 | 4,398 | 4,226 | 4,310 | 3,354 | 1,795 | Upgrade
|
| Gross Profit | 756.43 | 652.05 | 409.86 | 303.72 | 217.06 | 139.86 | Upgrade
|
| Selling, General & Admin | 88.3 | 70.27 | 47.49 | 41.93 | 30.82 | 19.84 | Upgrade
|
| Other Operating Expenses | 181.47 | 175.32 | 125.44 | 109.59 | 76.08 | 45.95 | Upgrade
|
| Operating Expenses | 299.2 | 267.8 | 185.38 | 160.59 | 115.56 | 73.22 | Upgrade
|
| Operating Income | 457.23 | 384.25 | 224.48 | 143.12 | 101.5 | 66.64 | Upgrade
|
| Interest Expense | -206.33 | -141.04 | -78.7 | -45.86 | -27.58 | -28.56 | Upgrade
|
| Interest & Investment Income | 5.55 | 5.55 | 7.88 | 4.9 | 1.99 | 0.25 | Upgrade
|
| Currency Exchange Gain (Loss) | 2.01 | 2.01 | 1.95 | 0.13 | 0.11 | 1.1 | Upgrade
|
| Other Non Operating Income (Expenses) | 21.42 | -6.3 | -3.33 | -4.95 | -3.67 | -3.69 | Upgrade
|
| EBT Excluding Unusual Items | 279.87 | 244.47 | 152.28 | 97.34 | 72.35 | 35.75 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | -2.37 | -0.99 | - | Upgrade
|
| Other Unusual Items | -16.48 | -28.17 | - | - | - | - | Upgrade
|
| Pretax Income | 263.39 | 216.29 | 152.28 | 94.96 | 71.36 | 35.75 | Upgrade
|
| Income Tax Expense | 59.59 | 56.77 | 37.73 | 24.6 | 18.87 | 9.03 | Upgrade
|
| Earnings From Continuing Operations | 203.8 | 159.53 | 114.55 | 70.37 | 52.49 | 26.71 | Upgrade
|
| Minority Interest in Earnings | 5.99 | 0.02 | - | - | -0.01 | - | Upgrade
|
| Net Income | 209.78 | 159.55 | 114.55 | 70.37 | 52.48 | 26.71 | Upgrade
|
| Net Income to Common | 209.78 | 159.55 | 114.55 | 70.37 | 52.48 | 26.71 | Upgrade
|
| Net Income Growth | 93.25% | 39.28% | 62.79% | 34.09% | 96.46% | 109.49% | Upgrade
|
| Shares Outstanding (Basic) | 248 | 242 | 239 | 241 | 144 | 153 | Upgrade
|
| Shares Outstanding (Diluted) | 251 | 242 | 239 | 241 | 144 | 153 | Upgrade
|
| Shares Change (YoY) | 3.91% | 1.30% | -0.83% | 66.88% | -5.63% | - | Upgrade
|
| EPS (Basic) | 0.85 | 0.66 | 0.48 | 0.29 | 0.36 | 0.17 | Upgrade
|
| EPS (Diluted) | 0.83 | 0.66 | 0.48 | 0.29 | 0.36 | 0.17 | Upgrade
|
| EPS Growth | 85.98% | 37.50% | 64.16% | -19.65% | 108.19% | 109.49% | Upgrade
|
| Free Cash Flow | - | 302.13 | 59.02 | -431.2 | -54.79 | 14.7 | Upgrade
|
| Free Cash Flow Per Share | - | 1.25 | 0.25 | -1.79 | -0.38 | 0.10 | Upgrade
|
| Dividend Per Share | - | - | - | 0.030 | - | - | Upgrade
|
| Gross Margin | 11.75% | 12.91% | 8.84% | 6.58% | 6.08% | 7.23% | Upgrade
|
| Operating Margin | 7.10% | 7.61% | 4.84% | 3.10% | 2.84% | 3.44% | Upgrade
|
| Profit Margin | 3.26% | 3.16% | 2.47% | 1.52% | 1.47% | 1.38% | Upgrade
|
| Free Cash Flow Margin | - | 5.98% | 1.27% | -9.35% | -1.53% | 0.76% | Upgrade
|
| EBITDA | 466.03 | 394.55 | 236.77 | 152.19 | 110.15 | 72.88 | Upgrade
|
| EBITDA Margin | 7.24% | 7.81% | 5.11% | 3.30% | 3.08% | 3.77% | Upgrade
|
| D&A For EBITDA | 8.8 | 10.3 | 12.29 | 9.07 | 8.66 | 6.24 | Upgrade
|
| EBIT | 457.23 | 384.25 | 224.48 | 143.12 | 101.5 | 66.64 | Upgrade
|
| EBIT Margin | 7.10% | 7.61% | 4.84% | 3.10% | 2.84% | 3.44% | Upgrade
|
| Effective Tax Rate | 22.63% | 26.24% | 24.78% | 25.90% | 26.45% | 25.27% | Upgrade
|
| Revenue as Reported | 483,271 | - | 4,661 | 4,624 | 3,576 | 1,937 | Upgrade
|
| Advertising Expenses | - | 0.21 | 0.28 | 0.07 | 0.04 | 0.09 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.